Prenatal low-level lead exposure and developmental delay of infants at age 6 months (Krakow inner city study)

Wieslaw Jedrychowski1, Frederica Perera, Jeffery Jankowski

  • 1Epidemiology and Preventive Medicine, Jagiellonian University, Collegium Medicum, Krakow, Poland. myjedryc@cyf-kr.edu.pl <myjedryc@cyf-kr.edu.pl>

Insights

Prenatal lead exposure in pregnant mothers is linked to lower infant visual recognition memory (VRM) scores. Reducing maternal blood lead levels may prevent developmental delays in infants.

Area of Science:

  • Environmental Health
  • Neurodevelopmental Pediatrics
  • Toxicology

Background:

  • Prenatal exposure to environmental toxins, such as lead (Pb), can impact infant neurodevelopment.
  • Assessing early cognitive function is crucial for identifying potential developmental risks.
  • Visual recognition memory (VRM) is a key indicator of infant cognitive status.

Purpose of the Study:

  • To evaluate the neurocognitive status of 6-month-old infants exposed to varying levels of lead in utero.
  • To determine the relationship between maternal prenatal lead exposure and infant visual recognition memory (VRM).

Main Methods:

  • A cohort of 452 infants born between 33-42 weeks gestation was studied.
  • Maternal lead exposure was assessed via cord blood lead levels.
  • Infant visual recognition memory (VRM) was measured using the Fagan Test of Infant Intelligence (FTII).

Main Results:

  • A significant inverse correlation was found between cord blood lead levels and infant VRM scores (Spearman r = -0.16, p=0.007).
  • Infants in the higher lead exposure group (>1.67 microg/dl) had significantly lower mean Fagan scores (58.4) compared to the lower exposed group (61.0).
  • Higher prenatal lead exposure (above 1.67 microg/dl) was associated with a two-fold increased risk of scoring in the high-risk group for developmental delay (OR=2.33).

Conclusions:

  • Prenatal lead exposure negatively impacts infant visual recognition memory and is associated with developmental delay risk.
  • Reducing maternal blood lead levels below 1.67 microg/dl could prevent approximately 50% of VRM deficits in exposed infants.
  • While a screening criterion based on cord blood lead levels shows promise, further refinement is needed due to its low positive predictive value.